Now that Allogene Therapeutics Inc’s volume has hit 1.2 million, investors get a glimpse of its size.
Allogene Therapeutics Inc (NASDAQ: ALLO) kicked off on Monday, down -3.78% from the previous trading day, before settling in for the closing price of $2.91.
